HANGZHOU, China and SHAOXING, China, Jan. 1, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), a commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Ganovo® (Danoprevir)...
from PR Newswire: http://bit.ly/2R0WSay
No comments:
Post a Comment